New Delhi: Mankind Pharma is all set to make its stock market debut on Tuesday, and looking at the grey market prices, market analysts believe that the scrip will have a bumper listing on bourses. 


Mankind Pharma IPO GMP


COMMERCIAL BREAK
SCROLL TO CONTINUE READING

As per reports, the Mankind Pharma latest GMP suggests a premium of Rs 120, suggesting that the scrip will have a remarkable debut on its stock market listing. 


Mankind IPO Stock Market Listing


Post the public subscription, the shares of Mankind Pharma are expected to go live on stock exchanges Tuesday (May 9, 2023).


Mankind IPO Details


The company's IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders. Those selling shares in the OFS are promoters Ramesh Juneja, Rajeev Juneja and Sheetal Arora. Besides, Cairnhill CIPEF, Cairnhill CGPE, Beige Limited, and Link Investment Trust will participate in the OFS. Since the IPO is completely an OFS, the company will not receive any net proceeds from the issue and the entire net proceeds will go to the selling shareholders.


Kotak Mahindra Capital Company, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India are the book-running lead managers to the issue.